InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Copeland Robert A. Director active across 1 company, notably Epizyme, Inc.. In total, 4 disclosures have been logged. Split: 0 buy · 2 sells. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Copeland Robert A is a declarant with 4 filings in total. The 4 sampled filings concern Epizyme, Inc., where he is President of Research and CSO, and they are all dated 2016-01-04. The modal transaction nature is Levée d'options, and the buy and sell amounts in the sampled recent filings are 0 and 0 EUR.